INS and type 1 diabetes mellitus: Clinically, it has been long known that patients with type 1 diabetes (T1D) have smaller pancreata and reduced exocrine function compared with nondiabetic controls (10–15), which implies that insulin or some other β cell component may serve as a growth or survival factor for the exocrine tissues (16, 17).